Non Serious Adverse Drug Reactions Report

Start Date:2016-04-13 End Date:2016-04-14
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0239Subject Initials :JJLDOB :01/25/1984Sex:FemaleRace:AsianHeight:158cmWeight:49.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment09/06/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/23/201509/27/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: incomplete right fallopian tube obstruction, left fallopian tube obstruction Uk-Mar-2015Not on treatment/medication
 



13-APR-16
NA/EMR700623-541/C02-0239
Page 1 of 12
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-13 End Date:2016-04-14
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0240Subject Initials :DMXDOB :01/01/1985Sex:FemaleRace:AsianHeight:155cmWeight:47.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment09/06/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/21/201509/26/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
Laparoscopy surgery: pelvic adhesions separation surgery, plastic surgery to repair the fallopian tubes, uterine cavity is normal.Uk-Unk-2013Not on treatment/medication
 



13-APR-16
NA/EMR700623-541/C02-0240
Page 2 of 12
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-13 End Date:2016-04-14
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0244Subject Initials :DDWDOB :09/13/1986Sex:FemaleRace:AsianHeight:160cmWeight:53.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment09/06/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/22/201509/27/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS occurs canceled embryo transfer, OHSS improvement
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: bilateral tubal patencyUk-Unk-2008Not on treatment/medication
 



13-APR-16
NA/EMR700623-541/C02-0244
Page 3 of 12
 

Non Serious Adverse Drug Reactions Report

Start Date:2016-04-13 End Date:2016-04-14
Study :EMR700623-541Investigator :NACountry of Investigator :ChinaSiteNo:C02
Subject No :C02-0247Subject Initials :BSHDOB :08/12/1987Sex:FemaleRace:AsianHeight:155cmWeight:40.0kg
First administration date of batch :Batch number :
Study DrugStart DateDoseChange in Dose
Gonal-f New Pen Stimulation Treatment09/07/2015150
Adverse EventStart DateEnd DateTime related to study treatmentCausality to study drugSeverity
OHSS09/23/201509/27/2015RelatedModerate
Causality FactorsAction Taken with Study TreatmentOther action takenOutcomeAE Special InterestAE dose limiting toxicity
None(Othervalue:)Not applicableLed to study terminationResolved
Event description:Moderate OHSS patients, improved canceled after embryo transfer.
Subject received concomitant medications:
Does the subject have any relevant past or present medical conditions:Yes
ConditionStart DateRelated to study conditionOngoing
HSG: the right fallopian tube obstruction, incomplete left fallopian tube obstruction Uk-Mar-2014Not on treatment/medication
Laparoscopy surgery: dissection of pelvic adhesions, tubal repair plastic surgery, and it was surgery.Uk-Apr-2014Not on treatment/medication
 



13-APR-16
NA/EMR700623-541/C02-0247
Page 4 of 12